AJP - Renal Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 275: F18-F24, 1998;
0363-6127/98 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ying, W.-Z.
Right arrow Articles by Sanders, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ying, W.-Z.
Right arrow Articles by Sanders, P. W.
Vol. 275, Issue 1, F18-F24, July 1998

Dietary salt enhances glomerular endothelial nitric oxide synthase through TGF-beta 1

Wei-Zhong Ying and Paul W. Sanders

Nephrology Research and Training Center, Comprehensive Cancer Center, and Cell Adhesion and Matrix Research Center, Division of Nephrology, Department of Medicine and Department of Physiology and Biophysics, University of Alabama at Birmingham, 35294-0007; and Department of Veterans Affairs Medical Center, Birmingham, Alabama 35233

    ABSTRACT
Top
Abstract
Introduction
Methods
Results
Discussion
References

Dietary salt controls production of nitric oxide (NO), a potent paracrine relaxation factor involved in glomerular filtration and salt excretion. We hypothesized that glomerular NO production was enhanced through endothelial nitric oxide synthase (NOS3). Rats in metabolic cages were studied after 4 days on 0.3% (Lo-salt) or 8.0% (Hi-salt) NaCl diet. Steady-state mRNA and protein levels of NOS3 and calcium-dependent NO production of isolated glomeruli from Hi-salt animals were greater than those values observed in glomeruli from Lo-salt rats. Because dietary salt enhanced glomerular production of transforming growth factor-beta 1 (TGF-beta 1) [W.-Z. Ying and P. W. Sanders. Am. J. Physiol. 274 (Renal Physiol. 43): F635-F641, 1998], studies were then conducted to examine the interaction between NOS3 and TGF-beta 1. Glomerular steady-state levels of mRNA of NOS3 and TGF-beta 1 directly correlated (r2 = 0.946; P < 0.0001). A neutralizing antibody to TGF-beta reduced NOS3 protein and NO production in cultured glomeruli from Hi-salt animals to levels seen in the Lo-salt glomeruli. Thus dietary salt increased glomerular expression of TGF-beta 1, which in turn augmented NO production through NOS3.

sodium chloride; nitric oxide; glomerulus; endothelial nitric oxide synthase; transforming growth factor-beta 1

    INTRODUCTION
Top
Abstract
Introduction
Methods
Results
Discussion
References

TO EXCRETE SALT in appropriate amounts, several systems monitor variations in dietary salt intake and effect changes in renal salt excretion. The renin-angiotensin-aldosterone axis is one such system. Recently, another factor, nitric oxide (NO), has been suggested to play an important role in salt balance (8-10, 16, 28, 33, 37). Dietary salt controls NO production in vivo (8, 33). Tolins and associates (36) demonstrated further that endogenous NO production was an important factor determining salt excretion and subsequent blood pressure response to a high-salt diet.

NO is a potent paracrine dilator. In the glomerulus, the mesangial cell is a principal site of action of NO. Mesangial cells attach to the basement membrane of the capillary to form a biomechanical unit (31, 32). Blantz and associates (3) demonstrated the importance of the mesangial cell in regulation of glomerular hemodynamics. These micropuncture studies of rats with mesangiolysis failed to demonstrate the standard increase in single-nephron glomerular filtration rate that occurs with plasma volume expansion. In addition, the decrease in glomerular ultrafiltration coefficient (Kf) that normally occurs with infusion of angiotensin II was not seen (3). By use of inhibitors of nitric oxide synthase (NOS), Deng and Baylis (15) showed that NO also regulates Kf, presumably through relaxation of the mesangial cell to increase the effective filtering surface area of the glomerulus. Because an increase in dietary salt expands plasma volume (14), we hypothesized that an expected compensation is augmented glomerular production of NO. The current studies sought to determine whether glomerular production of NO was enhanced by an increase in dietary salt and further to identify the potential mechanism involved.

    METHODS
Top
Abstract
Introduction
Methods
Results
Discussion
References

Animal preparation. Studies were conducted using 48 male Sprague-Dawley rats, 28 days of age, obtained from Charles River Laboratories (Wilmington, MA). Animals were chosen at this age because of our previous experience which showed normal renal function and blood pressure responses to dietary salt over 2 wk of observation (8). The rats were housed under standard conditions and given 0.3% NaCl diet (AIN-76A with 0.3% NaCl; Dyets, Bethlehem, PA) and water ad libitum for 4 days before initiating the experiment. The animals were then placed in metabolic cages and allowed free access to water and rat diet, which contained either 0.3% (termed "Lo-salt" group) or 8.0% (AIN-76A with 8.0% NaCl, Dyets; termed "Hi-salt" group) NaCl. Urine was collected under oil to prevent desiccation. Food consumption, urine flow, and body weight were recorded daily, and the experiment was concluded after the 4th day. The collected urine sample from each rat was filtered to remove any particulate matter and centrifuged at 325 g for 2 min at 4°C. The supernatant was collected and immediately frozen at -80°C until use. Urine samples were analyzed for sodium and potassium, using flame photometry (model IL-943; Instrumentation Laboratories, Lexington, MA). On the day of study, rats were anesthetized with a pentobarbital sodium (50 mg/kg ip) injection. Both kidneys were harvested under sterile conditions for isolation of glomeruli for in vitro incubation experiments and obtaining protein for Western blotting and total RNA for Northern hybridization.

Isolation of glomeruli. Glomeruli were isolated using a graded sieving technique. This protocol has been shown to produce pure and viable glomeruli for study of transforming growth factor-beta (TGF-beta ) and NO production (6, 20, 35, 38). The kidneys were perfused in situ through the aorta with cold isotonic heparinized saline until blanched (50-60 ml saline over 2 min). The renal cortices from each rat were individually dissected and minced to a pastelike consistency. The homogenate was passed successively through a 106-µm metal sieve that excluded blood vessels and a 75-µm nylon sieve that retained the glomeruli and allowed cells and small tubular segments to pass through. Glomeruli were washed three times with ice-cold PBS at 120 g for 5 min. The pelleted glomeruli were then used as described below for incubation studies, Western blotting, and Northern analysis. All glomerular preparations consisted of more than 95% glomeruli with minimal tubular contamination, as assessed visually at ×40 magnification.

Glomerular incubation studies. The pelleted glomeruli were resuspended at 5 × 103 glomeruli/ml of serum-free medium (RPMI 1640; Life Technologies, Grand Island, NY). Simultaneously obtained samples of glomeruli from Hi-salt and Lo-salt animals were placed in 24-well plates. Samples were initially incubated with medium alone or medium that contained 3 mM tetraethylammonium chloride (TEA; Sigma Chemical, St. Louis, MO) or 10 µg/ml rabbit polyclonal antibody that specifically neutralizes TGF-beta (catalog no. AB-100-NA; R & D Systems, Minneapolis, MN) in serum-free RPMI media at 37°C. TEA in this dose specifically inhibits potassium channels but is relatively nonselective (7, 12, 13, 25, 26) and has been used previously to examine TGF-beta production by endothelial cells (25). In some experiments, nonspecific rabbit IgG (10 µg/ml; Southern Biotechnology Associates, Birmingham, AL) was added as another control. After a 30-min incubation period, the medium was removed and replaced with serum-free medium alone or serum-free medium that contained the same concentrations of TEA or neutralizing antibody. Human TGF-beta 1 (0-10 ng/ml, R & D Systems) was added in some experiments. As described by others (18), to determine calcium-dependent NO production, some samples of each preparation also contained the calcium ionophore A-23187 (1 µM, Sigma Chemical). All samples were incubated for 24 h at 37°C; samples of conditioned media were then harvested stored at -20°C until assayed for nitrate, nitrite, and TGF-beta 1. The glomeruli were then processed for total protein assay and Western blotting, as described below.

Measurement of glomerular NO production. Concentrations of nitrate and nitrite, collectively termed NOx, in conditioned media were determined by methods described previously (10). All reagents were from Sigma. To determine NOx concentration, samples of medium, diluted 1:5 in deionized water and sodium nitrate standards (0-200 µM), were simultaneously reduced for 1 h at 37°C by Escherichia coli (ATCC no. 25922; American Type Culture Collection, Rockville, MD) grown previously under anerobic conditions. After centrifugation for 10 min at 1,000 g, 50 µl of supernatant were added to 50 µl of 1.0% sulfanilamide in 30% acetic acid and 50 µl of 0.1% N-(1-naphthyl)ethylenediamine dihydrochloride in 60% acetic acid (Griess reagent). After mixing, the optical density was read at 540 nm, using a microplate reader (THERMOmax; Molecular Devices, Menlo Park, CA).

TGF-beta 1 immunoassay. Active TGF-beta 1 in the medium was determined using an enzyme immunoassay (TGF-beta 1 Emax ImmunoAssay System; Promega, Madison, WI), following the protocol provided by the manufacturer. Briefly, plates containing 96 flat-bottom wells (Falcon; Becton Dickinson, Oxnard, CA) were coated overnight at 4°C with 100 µl of anti-TGF-beta 1 monoclonal antibody diluted 1:1,000 in buffer that contained 0.025 M sodium bicarbonate and 0.025 M sodium carbonate, pH 9.7. Thereafter, unbound sites in the wells were blocked using 270 µl of the blocking reagent supplied in the kit for 2 h at room temperature, then 100 µl of undiluted medium or TGF-beta 1 standard in sample buffer were added to wells. After incubation for 3 h at room temperature with vigorous shaking, the wells were washed five times with TBST wash buffer (20 mM Tris · HCl, pH 7.6, 150 mM NaCl, and 0.05% Tween 20), then 100 µl of polyclonal anti-TGF-beta 1 diluted in sample buffer were added. The plates were again incubated overnight at 4°C. After five washes with TBST buffer, wells were filled with 100 µl of antibody conjugated with horseradish peroxidase and incubated for 3 h at room temperature with shaking. After additional washes as in the previous steps, color was developed by adding 100 µl of peroxidase substrate in 3,3',5,5'-tetramethylbenzidine solution. After an ~10-min incubation at room temperature, 100 µl of 1 M phosphoric acid were added to stop the color reaction. Optical density was determined at 450 nm using a microplate reader (THERMOmax, Molecular Devices). Standards were performed in duplicate using TGF-beta 1 (7.8-1,000 pg/ml in sample buffer) and were used to construct standard curves from which the concentrations of the samples were determined.

Western blot analysis. Glomeruli that were freshly isolated from the Hi-salt and Lo-salt rats and glomeruli that were treated as described in the incubation studies described above were washed with PBS, then centrifuged at 200 g for 5 min at 4°C. The pellet was dissolved in RIPA buffer (in mM: 50 Tris · HCl, 150 NaCl, 1 disodium EDTA, 0.1 EGTA, 1.0% Nonidet P-40, 0.1% SDS, and 0.5% sodium deoxycholate). Phenylmethylsulfonyl fluoride (PMSF, 1 mM), 10 µg/ml aprotinin, and 10 µg/ml leupeptin were added as protease inhibitors. All of these inhibitors were from Sigma Chemical. Total protein of each sample was determined using a kit (Micro bicinchoninic acid protein assay reagent kit; Pierce, Rockford, IL), and the volume of each sample was adjusted to allow loading of 30 µg into each well. The samples were boiled in SDS-Laemmli sample buffer for 5 min, then the proteins were resolved using a 8% SDS-polyacrylamide gel electrophoresis and transferred to nitrocellulose membrane. After incubation in blocking buffer (10 mM Tris, pH 7.5, containing 5% nonfat dry milk, 100 mM NaCl, and 0.1% Tween 20), the membranes were probed with anti-human NOS3 monoclonal antibody (Transduction Laboratories, Lexington, KY), 1:1,000 dilution, in blocking buffer for 2 h at room temperature. The membranes were then washed five times with TBST and were incubated with horseradish peroxidase-conjugated anti-IgG antibody (Bio-Rad, Hercules, CA), 1:2,000 dilution, in blocking buffer. After three additional washes using TBST, the membrane was developed using ECL enhanced chemiluminescence Western blotting system and Hyperfilm (Amersham International, Buckinghamshire, UK). The films were scanned using a densitometer to quantify NOS3 (model 620 Video Densitometer, Bio-Rad).

Northern hybridization. Total RNA was isolated from freshly isolated glomeruli in standard fashion by single-step method of acid guanidinium thiocyanate-phenol-chloroform extraction (11). The concentration and purity of RNA in each sample were determined using optical density at 260 and 280 nm. Twenty micrograms of total RNA from each sample was resolved in 1.0% agarose gels containing 2.2 M formaldehyde and 0.2 M MOPS, pH 7.0, then transferred to a nylon membrane (Genescreen Plus Hybridization Transfer Membrane; NEN Life Science Products, Boston, MA) by vacuum blotting (model 785, Bio-Rad) for 2 h in 10× standard sodium citrate (SSC). Nucleic acids were cross-linked by ultraviolet irradiation (Stratagene, La Jolla, CA). The membranes were prehybridized for 20 min at 68°C in standard hybridization solution (QuikHyb, Stratagene). They were then hybridized at 68°C for 4 h with cDNA probes for rat TGF-beta 1 (kindly provided by Dr. Thomas S. Winokur, University of Alabama at Birmingham) and for bovine NOS3 (generously provided by Dr. William C. Sessa, Yale University School of Medicine). The cDNA probes, which consisted of an ~1-kb fragment that was produced by digestion of the TGF-beta 1 plasmid with Hind III and Xba I and included the entire coding region (17) and an ~4-kb fragment produced by digestion of the NOS3 plasmid with EcoR I, were labeled with [alpha -32P]dCTP by random oligonucleotide priming (Prime-a-Gene Labeling System, Promega). The blots were washed in 2× SSC with 0.1% SDS at room temperature for 30 min and in 0.1× SSC with 0.1% SDS at 60°C for 20-30 min. Membranes were exposed to XAR-5 film (Kodak) at -80°C. The blots were then stripped in solution containing 1 mM Tris · HCl, pH 8.0, 0.1 mM EDTA and 0.1× Denhardt's at 75°C for 2 h and rehybridized with human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) probe obtained through the American Type Culture Collection. Autoradiographs were scanned using a densitometer (model 620 Video Densitometer, Bio-Rad). The density of the GAPDH band in the same lane was used to normalize mRNA loading. For quantification, densities of the bands of TGF-beta 1 and NOS3 were individually divided by the density of band for GAPDH in the same lane.

Statistical analysis. All data are presented as means ± SE. Significant difference among data sets was determined using either the unpaired t-test or one-way analysis of variance with standard posthoc testing (Statview, version 4.5; Abacus Concepts, Berkeley, CA), where appropriate. P < 0.05 was statistically significant.

    RESULTS
Top
Abstract
Introduction
Methods
Results
Discussion
References

Mean body weight, food intake, urinary flow rate, urinary sodium excretion rate, and urinary potassium excretion rate of the 32 rats in this study were shown in Table 1. As expected, urinary flow rate and urinary sodium and potassium excretion rates of the Lo-salt group were less (P < 0.05) than the corresponding Hi-salt group.

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Comparison of physiological parameters of animals in this study

Steady-state mRNA and protein levels of NOS3 were determined using freshly isolated glomeruli from rats on the 8.0% and 0.3% NaCl diets. Northern analysis and Western blotting confirmed increased expression of NOS3 in glomeruli from the Hi-salt group (Figs. 1 and 2). Mean steady-state mRNA of TGF-beta 1 was also greater (0.632 ± 0.037 vs. 0.326 ± 0.032, P = 0.0008) in freshly isolated glomeruli from the Hi-salt group, compared with the Lo-salt group. Glomerular expressions of mRNA of NOS3 and TGF-beta 1 were linearly correlated (r2 = 0.946, P < 0.0001) (Fig. 3). With glomeruli in culture, production of active TGF-beta 1 was shown to be increased in rats on the Hi-salt diet (Fig. 4). Consistent with our previous results (42) and that published by Ohno et al. (25), the increase in production of TGF-beta 1 was abrogated by addition of TEA to the medium.


View larger version (37K):
[in this window]
[in a new window]
 
Fig. 1.   Northern hybridization showing steady-state mRNA levels of endothelial nitric oxide synthase (NOS3) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in freshly isolated glomeruli from high (Hi)-salt (n = 4) and low (Lo)-salt (n = 4) rats. Graph (bottom) is mean densities of NOS3 relative to GAPDH and shows increase (0.534 ± 0.05 vs. 0.161 ± 0.01, P = 0.0006) in relative mRNA levels of NOS3 in glomeruli of animals maintained on 8.0% NaCl (Hi-salt) diet, compared with those animals maintained on the 0.3% NaCl (Lo-salt) diet.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 2.   Western blot of NOS3 expression in freshly isolated glomeruli from Hi-salt (n = 4) or Lo-salt (n = 4) rats. Mean relative NOS3 expression in Hi-salt glomeruli was greater (1.058 ± 0.071 vs. 0.507 ± 0.89, P = 0.003) than Lo-salt glomeruli.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 3.   Steady-state mRNA levels of NOS3 and transforming growth factor-beta 1 (TGF-beta 1) obtained from freshly isolated glomeruli of eight rats (4 in each group) were directly correlated (r2 = 0.946, P < 0.0001).


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 4.   Production of active TGF-beta 1 by glomeruli isolated from Hi-salt (n = 4) and Lo-salt (n = 4) rats. Increase in TGF-beta 1 was abrogated by addition of 3 mM tetraethylammonium chloride (TEA) to the medium, as we showed previously (42).

NOS3 protein expression of isolated glomeruli in culture was enhanced by dietary salt (Fig. 5). Addition of either TEA or a neutralizing antibody to TGF-beta to the medium reduced these values to levels found in the Lo-salt group. Function of NOS3, determined in the presence of A-23187, was increased in glomeruli from the Hi-salt group; addition of either TEA or a neutralizing antibody to TGF-beta to the medium also reduced these values to levels found in the Lo-salt group (Fig. 6). To ensure that the effect of the antibody to TGF-beta was specific, additional Western blotting experiments were performed following incubation with either the neutralizing antibody or nonspecific rabbit IgG, 10 µg/ml (Fig. 7). Nonspecific rabbit IgG had no effect on NOS3 protein expression. In another study, TGF-beta 1 was added to the medium in concentrations between 0 and 10 ng/ml. Addition of TGF-beta 1 to glomeruli from the Hi-salt animals increased expression of NOS3 but had no effect on glomeruli from the Lo-salt animals (Fig. 8). Thus, although TGF-beta 1 was essential in stimulation of NOS3, dietary salt produced another factor that permitted TGF-beta 1 to promote NOS3 expression in glomeruli.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 5.   Western blot of NOS3 expression in glomeruli from Hi-salt (n = 4) or Lo-salt (n = 4) rats. Top: glomeruli had been incubated in medium alone or medium containing 3 mM TEA or a neutralizing antibody to 10 µg/ml TGF-beta (Ab) for 24 h prior to processing. Con, positive control. Bottom: results of quantification of the image. Addition of either TEA or Ab to the medium reduced (P = 0.0124) mean NOS3 expression in glomeruli from Hi-salt rats, compared with NOS3 expression from untreated glomeruli from Hi-salt rats, to levels similar to that seen in Lo-salt glomeruli. Neither TEA nor Ab reduced NOS3 expression in glomeruli from the Lo-salt rats.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 6.   NOx (NO-2 + NO-3) production by glomeruli isolated from Hi-salt (n = 4) and Lo-salt (n = 4) rats. In some experiments, glomeruli from the rats on the 8.0% NaCl diet were incubated in medium containing either 10 µg/ml neutralizing antibody to TGF-beta (Hi-salt + Ab) or 3 mM TEA (Hi-salt + TEA). Calcium ionophore A-23187-stimulated NOx release (243 ± 21 vs. 123 ± 12 nmol · h-1 · mg protein-1, P = 0.0003) was increased in glomeruli from Hi-salt rats, compared with glomeruli from the Lo-salt rats. Addition of either the antibody or TEA reduced production of NOx to levels comparable to that seen in the Lo-salt glomeruli.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 7.   Quantification of NOS3 protein content of isolated glomeruli incubated with 10 µg/ml neutralizing antibody to TGF-beta (anti-TGF-beta ) or 10 µg/ml nonspecific rabbit IgG for 24 h prior to processing. Experiments were performed, as described in METHODS. Eight rats from each group (Hi-salt and Lo-salt) were used in these studies. Because several gels were run in these experiments, optical density of the band from one of the Lo-salt groups in each gel was used as the lowest common denominator. As expected, addition of anti-TGF-beta decreased (P = 0.004) expression of NOS3 to levels seen in glomeruli from the Lo-salt group. Addition of nonspecific IgG had no effect on NOS3 protein expression. * P < 0.005, compared with corresponding values from the Lo-salt group.


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 8.   Quantification of glomerular NOS3 protein content following a 24-h incubation with 0-10 ng/ml human TGF-beta 1 following the protocol outlined in METHODS. This dosing range was used because the normal circulating concentration of TGF-beta 1 fell within this range (42). Eight rats from each group (Hi-salt and Lo-salt) were used in these studies. Because several gels were run in these experiments, optical density of the band from one of the Lo-salt groups in each gel was used as the lowest common denominator. Among the Hi-salt groups, increase in NOS3 expression at 10 ng/ml TGF-beta 1 was greater (P < 0.002) than those values at 0 and 1 ng/ml. NOS3 levels at all three concentrations of TGF-beta 1 were greater (P < 0.05) in the Hi-salt groups than in the corresponding Lo-salt groups.

    DISCUSSION
Top
Abstract
Introduction
Methods
Results
Discussion
References

TGF-beta 1 belongs to a family of five multifunctional peptide growth factors (29). TGF-beta 1 is produced in the glomerulus (2, 40, 43) and has come under increasing scrutiny because of the important role this growth factor plays in glomerular senescence (4, 5, 19, 24, 29, 38-41, 44). We recently examined the potential role of dietary salt in modifying TGF-beta 1 expression in the kidney (42). An increase in dietary salt produced sustained increases in TGF-beta 1 mRNA and protein expression in the glomerulus. This effect was inhibited by TEA, suggesting a shear stress-related mechanism (25, 27). In addition, previous studies have shown that TGF-beta 1 directly regulates expression of NOS3 in bovine endothelial cells in culture (18). Based on these data and other observations that showed plasma volume increased in rats on a Hi-salt diet (14), we hypothesized an increase in NO mediated through TGF-beta 1 in glomeruli of rats on a Hi-salt diet. One expected compensation by which NO facilitates salt excretion is the ability of NO to increase Kf (15). In the current study, an increase in dietary salt increased NOS3 mRNA and protein expression in freshly isolated glomeruli. Calcium-dependent NO production was also increased, confirming augmented NOS3 activity. NOS3 mRNA expression correlated linearly with TGF-beta 1 mRNA (Fig. 3). Importantly, both NOS3 protein expression and function were inhibited by addition of a neutralizing antibody to TGF-beta . Thus the combined data confirmed that dietary salt enhances expression of TGF-beta 1 through a TEA-sensitive mechanism, probably shear stress. In turn, TGF-beta 1 stimulated glomerular NO production through NOS3 expression.

The present data provided support for the work of Deng and Baylis (15), who showed a role of NO in glomerular hemodynamics and glomerular function. The current studies also suggested one potential source of augmented production of NO on a Hi-salt diet (33). Enhanced glomerular NO production produces favorable glomerular hemodynamics to facilitate salt excretion (3), presumably by relaxation of the mesangial cells. Certainly, other NOSs, in the kidney and other organs, are also involved in the increase in NO production by dietary salt (9, 21). Although our current studies were consistent with the role of changes in NO in response to dietary salt (8, 16, 33, 37), the data disagree with two previous reports (21, 34). Mattson and Higgons (21) used Western blotting to demonstrate that dietary salt increased expression of NOS3, along with NOS1 and NOS2, in the medulla, but an increase in NOS3 was not seen in the cortex. As suggested by the authors, one limitation of their study was the low expression of NOS3 in the cortex and use of cortical tissue; isolated glomeruli were not examined. Potentially, these factors obscured any potential differences that occur in glomeruli in response to dietary salt intake. In the second study, Singh and associates (34) utilized only semiquantitative RT-PCR to detect mRNA of NOS3 in microdissected glomeruli. Although this approach is technically very difficult and contains many pitfalls, we cannot otherwise explain their negative results. However, pooling large numbers of isolated glomeruli allowed successful comparison of steady-state mRNA of NOS3 using standard Northern hybridization analysis. Although differences between our data and the literature exist, our study used three different assays to show that steady-state mRNA, protein levels, and functional activity of NOS3 were all increased in glomeruli from rats on the Hi-salt diet. Our work provided in vivo correlation with the previously described role of TGF-beta 1 in expression of NOS3 in endothelial cells in culture (18).

The mechanism of regulation of NOS3 by TGF-beta 1 has been partially elucidated. Previous studies have shown that TGF-beta 1 upregulates mRNA expression of mouse alpha 2(I) collagen gene through activation of a nuclear factor-1 (NF-1) binding site in the promoter region (30). Inoue et al. (18) further demonstrated that TGF-beta 1 stimulated gene transcription directly by activation of a similar element in the NOS3 promoter. A recent intriguing study showed that TGF-beta 1 regulated CCAAT-binding transcription factor (CTF-1), the prototypic member of the NF-1 family of transcription factors, in part, through mobilization of intracellular calcium stores and activation of calcineurin and calmodulin-dependent protein kinase IV. Another unidentified pathway also participates in the process of induction of CTF-1 transcription by TGF-beta 1 (1). The role of Smad proteins in this signal cascade is currently unclear. Interestingly, although supplemental TGF-beta 1 increased NOS3 in glomeruli from rats on the Hi-salt diet, TGF-beta 1 had no effect on NOS3 production in glomeruli from rats on the Lo-salt diet. The reason for this difference is uncertain at present but may relate to a direct alteration in the signal transduction cascade known to stimulate NOS3 transcription by changes in dietary salt.

In summary, dietary salt enhanced glomerular production of TGF-beta 1 through a TEA-sensitive mechanism. TGF-beta 1 directly increased NOS3 expression and calcium-dependent NO production. Almost four decades ago, pioneering work of Meneely and associates (22, 23) demonstrated a direct link between dietary salt and life span in rats. As dietary salt was increased from 0.15 to 21%, blood pressure progressively increased and life span fell. Autopsy studies further suggested findings compatible with arteriolosclerosis and atherosclerosis, particularly in the kidneys, as well as glomerular damage. Enhanced glomerular production of TGF-beta 1 by dietary salt is one potential mechanism of damage, although the concomitant increase in NO mitigates this response. Thus a delicate balance in the glomerulus between TGF-beta 1 and NOS3 ensures an appropriate hemodynamic action without untoward effects. However, with endothelial dysfunction, NO production might fail and facilitate glomerulosclerosis. These concepts provide the foundation for further investigation.

    ACKNOWLEDGEMENTS

This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases Grant DK-46199 and the Office of Research and Development, Medical Research Service, Department of Veterans Affairs.

    FOOTNOTES

Address for reprint requests: P. W. Sanders, Division of Nephrology, Dept. of Medicine, 642 Lyons-Harrison Research Bldg., Univ. of Alabama at Birmingham, Birmingham, AL 35294-0007.

Received 21 November 1997; accepted in final form 25 February 1998.

    REFERENCES
Top
Abstract
Introduction
Methods
Results
Discussion
References

1.   Alevizopoulos, A., Y. Dusserre, U. Rüegg, and N. Mermod. Regulation of the transforming growth factor beta -responsive transcription factor CTF-1 by calcineurin and calcium/calmodulin-dependent protein kinase IV. J. Biol. Chem. 272: 23597-23605, 1997[Abstract/Free Full Text].

2.   Ando, T., S. Okuda, K. Tamaki, K. Yoshitomi, and M. Fujishima. Localization of transforming growth factor-beta and latent transforming growth factor-beta binding protein in rat kidney. Kidney Int. 47: 733-739, 1995[Medline].

3.   Blantz, R. C., F. B. Gabbai, B. J. Tucker, T. Yamamoto, and C. B. Wilson. Role of mesangial cell in glomerular response to volume and angiotensin II. Am. J. Physiol. 264 (Renal Fluid Electrolyte Physiol. 33): F158-F165, 1993[Abstract/Free Full Text].

4.   Border, W. A., N. A. Noble, T. Yamamoto, J. R. Harper, Y. Yamaguchi, M. D. Pierschbacher, and E. Ruoslahti. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 360: 361-364, 1992[Medline].

5.   Border, W. A., S. Okuda, L. R. Languino, M. B. Sporn, and E. Ruoslahti. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature 346: 371-374, 1990[Medline].

6.   Cattell, V., T. Cook, and S. Moncada. Glomeruli synthesize nitrite in experimental nephrotoxic nephritis. Kidney Int. 38: 1056-1060, 1990[Medline].

7.   Chen, G., and D. W. Cheung. Characterization of acetylcholine-induced membrane hyperpolarization in endothelial cells. Circ. Res. 70: 257-263, 1992[Abstract/Free Full Text].

8.   Chen, P. Y., and P. W. Sanders. L-arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J. Clin. Invest. 88: 1559-1567, 1991.

9.   Chen, P. Y., and P. W. Sanders. Role of nitric oxide synthesis in salt-sensitive hypertension in Dahl/Rapp rats. Hypertension 22: 812-818, 1993[Abstract/Free Full Text].

10.   Chen, P. Y., P. L. St. John, K. A. Kirk, D. R. Abrahamson, and P. W. Sanders. Hypertensive nephrosclerosis in the Dahl/Rapp rat: initial sites of injury and effect of dietary L-arginine administration. Lab. Invest. 68: 174-184, 1993[Medline].

11.   Chomczynski, P., and N. Sacchi. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159, 1987[Medline].

12.   Cook, N. S. The pharmacology of potassium channels and their therapeutic potential. Trends Pharmacol. Sci. 9: 21-28, 1988[Medline].

13.   Cooke, J. P., E. Rossitch, Jr., N. A. Andon, J. Loscalzo, and V. J. Dzau. Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. J. Clin. Invest. 88: 1663-1671, 1991.

14.   Davis, J. M., D. A. Häberle, and T. Kawata. The control of glomerular filtration rate and renal blood flow in chronically volume-expanded rats. J. Physiol. (Lond.) 402: 473-495, 1988[Abstract/Free Full Text].

15.   Deng, A., and C. Baylis. Locally produced EDRF controls preglomerular resistance and ultrafiltration coefficient. Am. J. Physiol. 264 (Renal Fluid Electrolyte Physiol. 33): F212-F215, 1993[Abstract/Free Full Text].

16.   Deng, X., W. J. Welch, and C. S. Wilcox. Renal vasoconstriction during inhibition of NO synthase: effects of dietary salt. Kidney Int. 46: 639-646, 1994[Medline].

17.   Flanders, K. C., T. S. Winokur, M. G. Holder, and M. B. Sporn. Hyperthermia induces expression of transforming growth factor-beta s in rat cardiac cells in vitro and in vivo. J. Clin. Invest. 92: 404-410, 1993.

18.   Inoue, N., R. C. Venema, H. S. Sayegh, Y. Ohara, T. J. Murphy, and D. G. Harrison. Molecular regulation of the bovine endothelial cell nitric oxide synthase by transforming growth factor-beta 1. Arterioscler. Thromb. Vasc. Biol. 15: 1255-1261, 1995[Abstract/Free Full Text].

19.   Isaka, Y., Y. Fujiwara, N. Ueda, Y. Kaneda, T. Kamada, and E. Imai. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney. J. Clin. Invest. 92: 2597-2601, 1993.

20.   Kitamura, M., T. Sütö, T. Yokoo, F. Shimizu, and L. G. Fine. Transforming growth factor-beta 1 is the predominant paracrine inhibitor of macrophage cytokine synthesis produced by glomerular mesangial cells. J. Immunol. 156: 2964-2971, 1996[Abstract].

21.   Mattson, D. L., and D. J. Higgins. Influence of dietary sodium intake on renal medullary nitric oxide synthase. Hypertension 27: 688-692, 1996[Abstract/Free Full Text].

22.   Meneely, G. R., and C. O. T. Ball. Experimental epidemiology of chronic sodium chloride toxicity and the protective effect of potassium chloride. Am. J. Med. 25: 713-725, 1958[Medline].

23.   Meneely, G. R., R. G. Tucker, W. J. Darby, and S. H. Auerbach. Chronic sodium chloride toxicity: hypertension, renal failure and vascular lesions. Ann. Intern. Med. 39: 991-998, 1953.

24.   Nakamura, T., D. Miller, E. Ruoslahti, and W. A. Border. Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-beta 1. Kidney Int. 41: 1213-1221, 1992[Medline].

25.   Ohno, M., J. P. Cooke, V. J. Dzau, and G. H. Gibbons. Fluid shear stress induces endothelial transforming growth factor beta-1 transcription and production. J. Clin. Invest. 95: 1363-1369, 1995.

26.   Ohno, M., G. H. Gibbons, V. J. Dzau, and J. P. Cooke. Shear stress elevates endothelial cGMP: role of a potassium channel and G protein coupling. Circulation 88: 193-197, 1993[Abstract/Free Full Text].

27.   Olesen, S.-P., D. E. Clapham, and P. F. Davies. Haemodynamic shear stress activates a K+ current in vascular endothelial cells. Nature 331: 168-170, 1988[Medline].

28.   Patel, A., S. Layne, D. Watts, and K. A. Kirchner. L-Arginine administration normalizes pressure natriuresis in the hypertensive Dahl rats. Hypertension 22: 863-869, 1993[Abstract/Free Full Text].

29.   Roberts, A. B., and M. B. Sporn. Transforming growth factor beta . Adv. Cancer Res. 51: 107-145, 1988[Medline].

30.   Rossi, P., G. Karsenty, A. B. Roberts, N. S. Roche, M. B. Sporn, and B. de Crombrugghe. A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-beta . Cell 52: 405-414, 1988[Medline].

31.   Sakai, T., and W. Kriz. The structural relationship between mesangial cells and basement membrane of the renal glomerulus. Anat. Embryol. (Berl.) 176: 373-386, 1987[Medline].

32.   Schlondorff, D. The glomerular mesangial cell: an expanding role for a specialized pericyte. FASEB J. 1: 272-281, 1987[Abstract].

33.   Shultz, P. J., and J. P. Tolins. Adaptation to increased dietary salt intake in the rat: role of endogenous nitric oxide. J. Clin. Invest. 91: 642-650, 1993.

34.   Singh, I., M. Grams, W.-H. Wang, T. Yang, P. Killen, A. Smart, J. Schnermann, and J. P. Briggs. Coordinate regulation of renal expression of nitric oxide synthase, renin, and angiotensinogen mRNA by dietary salt. Am. J. Physiol. 270 (Renal Fluid Electrolyte Physiol. 39): F1027-F1037, 1996[Abstract/Free Full Text].

35.   Tamaki, K., S. Okuda, M. Nakayama, T. Yanagida, and M. Fujishima. Transforming growth factor-beta 1 in hypertensive renal injury in Dahl salt-sensitive rats. J. Am. Soc. Nephrol. 7: 2578-2589, 1996[Abstract].

36.   Tolins, J. P., R. M. J. Palmer, S. Moncada, and L. Raij. Role of endothelium-derived relaxing factor in regulation of renal hemodynamic responses. Am. J. Physiol. 258 (Heart Circ. Physiol. 27): H655-H662, 1990[Abstract/Free Full Text].

37.   Tolins, J. P., and P. J. Shultz. Endogenous nitric oxide synthesis determines sensitivity to the pressor effect of salt. Kidney Int. 46: 230-236, 1994[Medline].

38.   Tomooka, S., W. A. Border, B. C. Marshall, and N. A. Noble. Glomerular matrix accumulation is linked to inhibition of the plasmin protease system. Kidney Int. 42: 1462-1469, 1992[Medline].

39.   Yamamoto, T., T. Nakamura, N. A. Noble, E. Ruoslahti, and W. A. Border. Expression of transforming growth factor beta  is elevated in human and experimental diabetic nephropathy. Proc. Natl. Acad. Sci. USA 90: 1814-1818, 1993[Abstract/Free Full Text].

40.   Yamamoto, T., N. A. Noble, A. H. Cohen, C. C. Nast, A. Hishida, L. I. Gold, and W. A. Border. Expression of transforming growth factor-beta isoforms in human glomerular diseases. Kidney Int. 49: 461-469, 1996[Medline].

41.   Yamamoto, T., N. A. Noble, D. E. Miller, and W. A. Border. Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis. Kidney Int. 45: 916-927, 1994[Medline].

42.   Ying, W.-Z., and P. W. Sanders. Dietary salt modulates renal production of transforming growth factor-beta in rats. Am. J. Physiol. 274 (Renal Physiol. 43): F635-F641, 1998[Abstract/Free Full Text].

43.   Yoshioka, K., T. Takemura, K. Murakami, M. Okada, S. Hino, H. Miyamoto, and S. Maki. Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys. Lab. Invest. 68: 154-163, 1993[Medline].

44.   Zhu, L., G. A. Herrera, J. E. Murphy-Ullrich, Z.-Q. Huang, and P. W. Sanders. Pathogenesis of glomerulosclerosis in light chain deposition disease: role for transforming growth factor-beta . Am. J. Pathol. 147: 375-385, 1995[Abstract].


Am J Physiol Renal Physiol 275(1):F18-F24
0002-9513/98 $5.00 Copyright © 1998 the American Physiological Society



This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
W.-Z. Ying, K. Aaron, and P. W. Sanders
Mechanism of dietary salt-mediated increase in intravascular production of TGF-{beta}1
Am J Physiol Renal Physiol, August 1, 2008; 295(2): F406 - F414.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. Shen, M. Hagiwara, Y.-Y. Yao, L. Chao, and J. Chao
Salutary Effect of Kallistatin in Salt-Induced Renal Injury, Inflammation, and Fibrosis via Antioxidative Stress
Hypertension, May 1, 2008; 51(5): 1358 - 1365.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Cordaillat, A. Fort, A. Virsolvy, J.-L. Elghozi, S. Richard, and B. Jover
Nitric oxide pathway counteracts enhanced contraction to membrane depolarization in aortic rings of rats on high-sodium diet
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2007; 292(4): R1557 - R1562.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
Y. Bai, S. Ye, R. Mortazavi, V. Campese, and N. D. Vaziri
Effect of renal injury-induced neurogenic hypertension on NO synthase, caveolin-1, AKt, calmodulin and soluble guanylate cyclase expressions in the kidney
Am J Physiol Renal Physiol, March 1, 2007; 292(3): F974 - F980.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
W.-Z. Ying and P. W. Sanders
Enhanced expression of EGF receptor in a model of salt-sensitive hypertension
Am J Physiol Renal Physiol, August 1, 2005; 289(2): F314 - F321.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
P.-X. Wang and P. W. Sanders
Mechanism of hypertensive nephropathy in the Dahl/Rapp rat: a primary disorder of vascular smooth muscle
Am J Physiol Renal Physiol, January 1, 2005; 288(1): F236 - F242.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
W.-Z. Ying and P. W. Sanders
The interrelationship between TGF-{beta}1 and nitric oxide is altered in salt-sensitive hypertension
Am J Physiol Renal Physiol, November 1, 2003; 285(5): F902 - F908.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. Komers and S. Anderson
Paradoxes of nitric oxide in the diabetic kidney
Am J Physiol Renal Physiol, June 1, 2003; 284(6): F1121 - F1137.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H. W. Schnaper, T. Hayashida, S. C. Hubchak, and A.-C. Poncelet
TGF-beta signal transduction and mesangial cell fibrogenesis
Am J Physiol Renal Physiol, February 1, 2003; 284(2): F243 - F252.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Loscalzo
Salt-Sensitive Hypertension and Inducible Nitric Oxide Synthase: Form-Function Dichotomy of a Coding Region Mutation, Mutatis Mutandis
Circ. Res., August 17, 2001; 89(4): 292 - 294.
[Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. J. Solhaug, U. Kullaprawithaya, X. Q. Dong, and K.-W. Dong
Expression of endothelial nitric oxide synthase in the postnatal developing porcine kidney
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2001; 280(5): R1269 - R1275.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
L. J. Millatt and H. M. Siragy
Age-Related Changes in Renal Cyclic Nucleotides and Eicosanoids in Response to Sodium Intake
Hypertension, February 1, 2000; 35(2): 643 - 647.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. Braam
Renal endothelial and macula densa NOS: integrated response to changes in extracellular fluid volume
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 1999; 276(6): R1551 - R1561.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
W.-Z. Ying, H. Xia, and P. W. Sanders
Nitric Oxide Synthase (NOS2) Mutation in Dahl/Rapp Rats Decreases Enzyme Stability
Circ. Res., August 17, 2001; 89(4): 317 - 322.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ying, W.-Z.
Right arrow Articles by Sanders, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ying, W.-Z.
Right arrow Articles by Sanders, P. W.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online